Swabb Edward 4
4 · Myriad Pharmaceuticals, Inc. · Filed Jul 6, 2009
Insider Transaction Report
Form 4
Swabb Edward
SVP, Drug Development, CMO
Transactions
- Award
Common Stock
2009-07-01+15,000→ 15,000 total
Footnotes (1)
- [F1]Consists of a restricted stock unit award made pursuant to the Issuer's 2009 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest over a three-year period as to 1/3 of the units on each of June 15, 2010, June 15, 2011 and June 15, 2012.